• 1
    Smythe HA: Fibrositis and other diffuse musculoskeletal syndromes, Textbook of Rheumatology. Edited by WNKelley, EDHarrisJr, SRuddy, CSledge. Philadelphia, WB Saunders, 1985
  • 2
    Yunus MB, Masi AT, Calabro JJ, Miller KA, Feigenbaum SL: Primary fibromyalgia (fibrositis): clinical study of 50 patients with matched controls. Semin Arthritis Rheum 11: 151171, 1981
  • 3
    Lewis T, Kellgren JH: Observations relating to referred pain, visceromotor reflexes and other associated phenomena. Clin Sci 4: 4771, 1939
  • 4
    Moldofsky H, Scarisbrick P, England R, Smythe HA: Musculoskeletal symptoms and Non-REM sleep disturbance in patients with “fibrositis syndrome” and healthy subjects. Psychosom Med 37: 341351, 1975
  • 5
    Moldofsky H, Scarisbrick P: Induction of neurasthenic musculoskeletal pain syndrome by selective sleep stage deprivation. Psychosom Med 38: 3544, 1976
  • 6
    Payne TC, Leavitt F, Garron DC, Katz RS, Golden HE, Glickman PB, Vanderplate C: Fibrositis and psychologic disturbance. Arthritis Rheum 25: 213217, 1982
  • 7
    Ahles TA, Yunus MB, Riley SD, Bradley JM, Masi AT: Psychological factors associated with primary fibromyalgia syndrome. Arthritis Rheum 27: 11011106, 1984
  • 8
    Wolfe F, Cathey MA, Kleinheksel SM, Amos SP, Hoffman RG, Young DY, Hawley DJ: Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol 11: 500506, 1984
  • 9
    Bennett RM, Clark SR, Goldberg L, Nelson D, Bonafede RP, Porter J, Specht D: Aerobic fitness in patients with fibrositis: a controlled study of respiratory gas exchange and 133xenon clearance from exercising muscle. Arthritis Rheum 32: 454460, 1989
  • 10
    Russell IJ: Neurohormonal aspects of fibromyalgia syndrome. Rheum Dis North Am 15: 149168, 1989
  • 11
    Felson DT, Goldenberg DL: The natural history of fibromyalgia. Arthritis Rheum 29: 15221526, 1986
  • 12
    Hawley DJ, Wolfe F, Cathey MA: Pain, functional disability and psychological status: a 12 month study of severity in fibromyalgia. J Rheumatol 15: 15511556, 1988
  • 13
    Carette S, McCain GA, Bell DA, Fam AG: Evaluation of amitriptyline in primary fibrositis: a double-blind, placebo-controlled study. Arthritis Rheum 29: 655659, 1986
  • 14
    Goldenberg DL, Felson DT, Dinerman H: A randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 29: 13711377, 1986
  • 15
    Scudds RA, McCain GA, Rollman GB, Harth M: Improvements in pain responsiveness in patients with fibrositis after successful treatment with amitriptyline. J Rheumatol 16 (suppl 19): 98103, 1989
  • 16
    Jaeschke R, Adachi J, Guyatt G, Keller J, Wong B: Clinical usefulness of amitriptyline in fibromyalgia: the results of 23 N-of-1 randomized controlled trials. J Rheumatol 18: 447451, 1991
  • 17
    Bennett RM, Gutter RA, Campbell SM, Andrews RP, Clark SR, Scarola JA: A comparison of cyclobenzaprine and placebo in the management of fibrositis: a double-blind controlled study. Arthritis Rheum 31: 15351542, 1988
  • 18
    Quimby LG, Gratwick GM, Whitney CD, Block SR: A randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 16 (suppl 19): 140143, 1989
  • 19
    Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, Tugwell P, Campbell SM, Abeles M, Clark P, Fam AG, Farber SJ, Fiechtner JJ, Franklin CM, Gatter RA, Hamaty D, Lessard J, Lichtbroun AS, Masi AT, McCain GA, Reynolds WJ, Romano TJ, Russell IJ, Sheon RP: The American College of Rheumatology 1990 criteria for the classification of fibromyalgia: report of the multicenter criteria committee. Arthritis Rheum 33: 160172, 1990
  • 20
    Melzack R: The McGill Pain Questionnaire: major properties and scoring methods. Pain 1: 277199, 1975
  • 21
    Bergner M, Bobbin RA, Carter WB, Gilson BS: The Sickness Impact Profile: development and final revision of a health status measure. Med Care 19: 787805, 1981
  • 22
    Fries JF, Spitz PW, Kraines RG, Holman HR: Measurement of patient outcome in arthritis. Arthritis Rheum 23: 137145, 1980
  • 23
    Deyo RA, Diehl AK: Measuring physical discal and psychosocial function in patients with low back pain. Spine 8: 635642, 1983
  • 24
    Cathey MA, Wolfe F, Kleinheksel SM, Miller S, Pitetti KH: Functional ability and work status in patients with fibromyalgia. Health Care Res 1: 8598, 1988
  • 25
    Meenan RF, Gertman PM, Mason JH: Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum 23: 146152, 1980
  • 26
    Hathaway SR, McKinley JC: The Minnesota Multiphasic Personality Inventory. New York, The Psychological Corporation, 1943
  • 27
    Goldenberg DL: Treatment of fibromyalgia syndrome. Rheum Dis Clin North Am 15: 6171, 1989
  • 28
    Simms RW, Felson DT, Goldenberg DL: Criteria for response to treatment in fibromyalgia (abstract). Arthritis Rheum 31 (suppl 4): S100, 1988
  • 29
    Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG: Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam: a double-blind, placebo-controlled study. Arthritis Rheum 34: 552560, 1991
  • 30
    Gabriel SE, Bombardier C: Clinical trials in fibrositis: a critical review and future directions. J Rheumatol 16 (suppl 19): 177179, 1989
  • 31
    Carette S, Marcoux S, Truchon R, Grondin C, Gagnon J, Allard Y, Latulippe M: A controlled trial of corticosteroid injections into facet joints for chronic low back pain. N Engl J Med 325: 10021007, 1991
  • 32
    Smythe HA: Problems with the MMPI. J Rheumatol 11: 417419, 1984
  • 33
    Leavitt F, Katz RS: Is the MMPI invalid for assessing psychological disturbance in pain related organic conditions? J Rheumatol 16: 521526, 1989
  • 34
    Yunus MB, Ahles TA, Aldag JC, Masi AT: Relationship of clinical features with psychological status in primary fibromyalgia. Arthritis Rheum 34: 1521, 1991